Pfizer has resolved U.S. Department of Justice (DOJ) and Securities and Exchange Commission (SEC) matters related to improper operations payments in two of its subsidiaries outside the U.S. Pfizer had voluntarily reported these to the U.S. government beginning in 2004. To resolve the issues, Pfizer H.C.P. Corp. will enter into a deferred prosecution agreement with the DOJ, and pay a fine of $15 million. Under the terms of a civil settlement with the SEC, Pfizer agreed to discharge profits of $16...